Bo Kruse insider trades: Y-mAbs Therapeutics (YMAB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bo reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 31, 2024 | YMAB | ↓ Sell | 60,000 | $12.05 | $723K | Direct | May 31, 2024 (0d) |
| Feb 22, 2022 | YMAB | ↓ Sell | 4,000 | $7.85 | $31K | Direct | Feb 23, 2022 (1d) |
| Feb 4, 2022 | YMAB | ↓ Sell | 4,000 | $7.97 | $32K | Direct | Feb 7, 2022 (3d) |
| Jan 24, 2022 | YMAB | ↓ Sell | 4,000 | $9.84 | $39K | Direct | Jan 25, 2022 (1d) |
| Jan 4, 2022 | YMAB | ↓ Sell | 4,000 | $17.12 | $68K | Direct | Jan 5, 2022 (1d) |
| Dec 22, 2021 | YMAB | ↓ Sell | 4,000 | $16.36 | $65K | Direct | Dec 23, 2021 (1d) |
| Dec 6, 2021 | YMAB | ↓ Sell | 4,000 | $16.35 | $65K | Direct | Dec 7, 2021 (1d) |
| Nov 22, 2021 | YMAB | ↓ Sell | 4,000 | $18.09 | $72K | Direct | Nov 23, 2021 (1d) |
| Nov 4, 2021 | YMAB | ↓ Sell | 4,000 | $27.54 | $110K | Direct | Nov 5, 2021 (1d) |
| Oct 22, 2021 | YMAB | ↓ Sell | 4,000 | $25.94 | $104K | Direct | Oct 26, 2021 (4d) |
| Oct 4, 2021 | YMAB | ↓ Sell | 4,000 | $28.78 | $115K | Direct | Oct 5, 2021 (1d) |
| Sep 22, 2021 | YMAB | ↓ Sell | 4,000 | $30.82 | $123K | Direct | Sep 23, 2021 (1d) |
| Sep 7, 2021 | YMAB | ↓ Sell | 4,000 | $32.03 | $128K | Direct | Sep 8, 2021 (1d) |
| Aug 23, 2021 | YMAB | ↓ Sell | 4,000 | $28.60 | $114K | Direct | Aug 24, 2021 (1d) |
| Aug 4, 2021 | YMAB | ↓ Sell | 4,000 | $33.72 | $135K | Direct | Aug 5, 2021 (1d) |
| Jul 22, 2021 | YMAB | ↓ Sell | 4,000 | $34.50 | $138K | Direct | Jul 26, 2021 (4d) |
| Jul 6, 2021 | YMAB | ↓ Sell | 4,000 | $34.15 | $137K | Direct | Jul 7, 2021 (1d) |
| Jun 22, 2021 | YMAB | ↓ Sell | 4,000 | $36.17 | $145K | Direct | Jun 23, 2021 (1d) |
| Jun 4, 2021 | YMAB | ↓ Sell | 4,000 | $33.48 | $134K | Direct | Jun 7, 2021 (3d) |
| May 24, 2021 | YMAB | ↓ Sell | 4,000 | $35.61 | $142K | Direct | May 26, 2021 (2d) |
| May 14, 2020 | YMAB | ↓ Sell | 57,077 | $36.65 | $2.1M | By Investeringsselskabet G.H. ApS | May 15, 2020 (1d) |
| May 14, 2020 | YMAB | ↓ Sell | 42,923 | $36.66 | $1.6M | Direct | May 15, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bo Kruse's insider trades
Bo Kruse is EVP, CFO, Secry & Treas. at Y-mAbs Therapeutics (YMAB). Since May 14, 2020, Bo has reported no open-market purchases and 22 sales worth $6.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every YMAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.